Tullman Stephen A.

CIK 00016543431 companyMALVERN, PA

Transactions

Companies

Filings

CIK

0001654343

Recent Transactions

16 trades

Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-10-04$14.00/sh+7,100→ 177,457 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-08-23$15.00/sh+6,600→ 170,357 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-08-15$15.97/sh+6,250→ 163,757 total
Purchase
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-04-06$16.54/sh+26,700→ 157,507 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-03-16−94,151→ 0 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2018-03-16+9,018→ 130,807 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-09-15+144,153→ 144,153 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-09-15−50,002→ 94,151 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-09-15+4,790→ 121,789 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-09-15+116,999→ 116,999 total
Other
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2016-09-15−521,739→ 0 total
Award
Aclaris Therapeutics, Inc.$ACRS
Stock option (right to buy)
2015-12-18+7,095→ 7,095 total
Conversion
Aclaris Therapeutics, Inc.$ACRS
Series C Preferred Stock
2015-10-13−17,437→ 0 total
Conversion
Aclaris Therapeutics, Inc.$ACRS
Common Stock
2015-10-13+46,188→ 394,014 total
Conversion
Aclaris Therapeutics, Inc.$ACRS
Series A Preferred Stock
2015-10-13−110,000→ 0 total
Conversion
Aclaris Therapeutics, Inc.$ACRS
Series B Preferred Stock
2015-10-13−31,913→ 0 total

C/O ACLARIS THERAPEUTICS, INC. 101 LINDENWOOD DRIVE, SUITE 400

MALVERN, PA, 19355